US$ 22.51
ulcerative colitis glp-1 The Potential for GLP-1s in the Treatment of Weight Loss Medications & IBD
Description
It is becoming one of the biggest growth opportunities in pharmaceutical history, with analysts projecting the market to exceed hundreds of billions of dollars over the coming decade

Methods This systematic review was conducted across PubMed/MEDLINE and Web of Science
Treatment guidelines focus on nutrition, exercise, and pharmacologic therapies to prevent and manage complications

Here's what you need to know and how to save 10%.

There is no one-size-fits-all approach, and ongoing support can play a critical role in helping patients maintain their progress
